Related Experiment Video
Updated: Mar 26, 2026

03:07
Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
1.4K
Young breast cancer: A single center experience
1Department of Medical Oncology, Dr. B. R. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.
Indian Journal of Cancer
|February 5, 2016
Summary
Young women under 35 diagnosed with breast cancer often present with advanced disease. Triple-negative breast cancer in this demographic is common and linked to poorer outcomes, highlighting the need for targeted research.
Area of Science:
- Oncology
- Clinical Research
- Epidemiology
Background:
- Breast cancer in women under 35 is rare in Western countries (1-2% of cases).
- Limited data exists on young breast cancer patients in India.
- This study addresses the clinical and pathological characteristics of early-onset breast cancer.
Purpose of the Study:
- To analyze clinical and pathological factors in young breast cancer patients.
- To determine prognostic indicators and outcomes for early-onset breast cancer.
- To understand the specific challenges of breast cancer in women under 35 in India.
Main Methods:
- Retrospective analysis of 251 patients aged 35 or younger.
- Data collected from 2001-2011 at a single institute.
- Evaluation of clinical presentation, tumor characteristics, treatment, and survival.
Main Results:
- Median age of patients was 31 years; 8% of all breast cancer cases.
- Advanced stage (III/IV) at presentation in 77% of patients.
- High grade (40%), node-positive disease (60%), and triple-negative status (31%) were common.
- Median tumor size was 5.1 cm; modified radical mastectomy was frequent (79%).
- Estrogen receptor (ER), Progesterone receptor (PR), and HER2/neu positivity rates were 33% and 29% respectively.
- Three-year relapse-free survival was 51%, and overall survival was 66%.
Conclusions:
- Young women represent a significant proportion (8%) of breast cancer cases.
- Advanced stage at diagnosis and triple-negative status are key factors associated with poor outcomes.
- Early-onset breast cancer in this cohort exhibits aggressive features requiring specific management strategies.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Treatment Resistent Cancers
1.5K
1.5K
Cancer Survival Analysis
822
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
822

